| Range |
10,000,000 hepC: 1,200,000 hepB Cases
|
| Organism |
Human Homo sapiens |
| Reference |
Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011 Jul 27 p.578 left column 2nd and bottom paragraphsPubMed ID21802134
|
| Comments |
After extrapolation to all countries, researchers estimated that
about 10.0 million IDUs (range 6.0–15.2) in 2010
were anti-HCV positive (table 6 a midpoint prevalence
of 67.0% in IDUs globally). Researchers estimate that globally in 2010, 1.2 million
(range 0.3–2.7) IDUs were HBsAg positive. |
| Entered by |
Uri M |
| ID |
106627 |